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Background: The rate of decline in lung cancer risk after smoking
cessation among male population and the importance of the magni-
tude of the early decline were not sufficiently defined in the earlier
studies. We evaluated the detailed duration-response relationship
between years since smoking cessation and lung cancer risk across
major histological types in a population-based case-referent study.
Methods: We recruited 1208 consecutive incident cases of primary
lung cancer among Chinese males from the largest oncology center
in Hong Kong during 2004–2006, and 1069 male community
referents frequency-matched in 5-year age groups. We performed
unconditional multiple logistic regression and generalized additive
model incorporating smoothing spline to model the potential non-
linear effect of years since cessation on lung cancer.
Results: All histological types of lung cancer were strongly asso-
ciated with current smoking. We observed a rapidly decreasing odds
ratio of lung cancer (50%) across all major histological types of
lung cancer (except for the large cell type) within the first 5 years of
quitting; the odds ratio continued to decrease but at a slower rate in
the subsequent years.
Conclusion: The substantial benefits obtainable within a short
period of 5 years’ abstinence should convey an encouraging mes-
sage to chronic smokers, clinicians, and public health workers.
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(J Thorac Oncol. 2011;6: 1670–1676)
Lung cancer remains a leading lethal cancer worldwide,including Hong Kong.1 About 60% of lung cancer among
Chinese males and more than 80% among Western males
could be attributable to cigarette smoking.2 Many studies
examined the duration-response relationship between years
since smoking cessation and lung cancer risk and observed a
greater decline in the risk estimate for squamous cell
carcinoma (SQCC) and small cell carcinoma (SCC) than
adenocarcinoma (ADC).3 The rate of decline after smoking
cessation had been examined in the Nurse’s Health Study
among women, but the results may not be generalized to
the male population as a gender difference in lung cancer
etiology may exist4; in addition, the importance of the
magnitude of the early decline was not sufficiently ad-
dressed in the earlier studies.
Most previous studies estimated the association with
lung cancer by either categorizing the years since smoking
cessation or using conventional parametric general linear
models. The former uses “artificial” cut-points that may not
have biological basis and the latter imposes an a priori simple
linear relationship that could deviate from reality. These
shortcomings can be overcome by using the smoothing spline
modeling approach, which is more flexible, informative, and
accurate in analyzing an exposure-response relationship, and
allows the data to speak for itself.5 Being one of the largest
population-based case-referent lung cancer studies in Asian
men, this study aimed at examining the detailed duration-
response relationship between years since smoking cessation
and the risk of lung cancer across major histological types,
using both the conventional ordinal categorical analysis and
the more flexible smoothing spline modeling.
METHODS
Recruitment of Study Subjects
Eligible cases were Chinese males aged 35 to 79 years
with newly diagnosed primary carcinomas of the lung (Interna-
tional Classification of Disease [ICD], Revision 9, code 162)
that were histologically confirmed according to the World
Health Organization histological typing of lung tumors.6 Cases
were recruited consecutively from the largest oncology center in
Hong Kong from February 1, 2004, to September 30, 2006, and
were interviewed within 3 months after diagnosis. Among 1259
eligible cases, 1208 were interviewed with a response rate of
96%, 35 cases could not respond due to poor medical condition,
and 16 refused because of lack of interest.
Referents with no history of physician-diagnosed can-
cer in any site were randomly selected from residents of
districts where the cases came from, using residential tele-
phone directories, and were frequency-matched in 5-year age
groups according to the age distribution of incident lung
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cancer cases. We replaced the referent who refused to par-
ticipate by another similar referent from the same district of
the case. We finally recruited 1069 community referents with
a response rate of 48%, which was considered to be not low
compared with other similar population-based case-referent
studies. The main reasons for nonparticipation were lack of
time or no interest. This research was approved by the ethical
committees of both the Chinese University of Hong Kong and
the Queen Elizabeth Hospital.
Data Collection and Interviews
Trained interviewers conducted personal interviews
immediately after informed consents were obtained. A stan-
dardized structured questionnaire was used to obtain infor-
mation on lifetime consumption of tobacco and most known
potential confounding factors. Relevant medical information
of cases including medical diagnosis, ICD codes, and histo-
logical findings was abstracted from hospital records.
Assessment of Tobacco Smoking
We asked the respondents about their lifetime con-
sumptions of various types of tobacco products, including
cigarettes, Chinese prepared tobacco, and cigars. One who
had ever smoked more than 20 packs of cigarettes (one
pack  20 cigarettes) or 12 oz of tobacco in his lifetime, or
more than 1 cigarette a day or more than 1 cigar a week for
1 year was defined as an ever smoker.7 Otherwise, a subject
was classified as a never smoker. Ever smokers were asked to
report the amount of each type of tobacco consumed during
lifetime, the age at smoking initiation, and the age at smoking
cessation. Less than 5% cases and referents reported ever use
of Chinese prepared tobacco or cigar smoking.
Indices of cigarette smoking used in the analysis
included smoking status (never, former, and current) and
smoking cessation (age at smoking cessation and years
since smoking cessation). Other variables related to ciga-
rette smoking were age at smoking initiation, intensity
(average number of cigarettes smoked per day), years of
smoking, and pack-years.
Potential Confounding Factors
Most known potential confounding factors were col-
lected,9 including residential radon exposure, lifetime envi-
ronmental tobacco smoke exposure (workplace and house-
hold exposures), other sources of indoor air pollutants (years
of cooking by frying, type of fuel use, incense burning, and
use of mosquito coils), dietary habits, alcohol drinking habits,
history of lung diseases, cancer history in first-degree rela-
tives, education level, place of birth, and exposures to known
or suspected occupational lung carcinogens. Exposure to
known and suspected occupational lung carcinogens was
defined as ever regularly exposed to any of these agents:
silica, asbestos, arsenic, nickel, chromium, tars, asphalts,
painting, pesticide, diesel, cooking fume, and welding fume
in the workplace. A reduced version of the Diet History
Questionnaire designed by the National Cancer Institute
(USA) was used to collect the information on diet.10
Test-Retest Reliability
We invited 30% of the cases and referents to participate
in a second interview 2 months later after the initial interview
to evaluate the reliability of the recall of lifetime tobacco use;
276 lung cancer cases and 286 community referents re-
sponded to the second interview.
Statistical Analysis
Two-tailed 2 tests or independent t tests were used to
compare various indices of cigarette smoking and other major
risk factors between the cases and referents. Cohen’s kappa and
intraclass correlation coefficient were used to estimate the reli-
ability of categorical variables and ordinal or continuous vari-
ables, respectively. Unconditional multiple logistic regression
models were applied to calculate the odds ratio (OR) and the
95% confidence interval (95% CI) of various indices of
cigarette smoking after adjusting for age only or age and
other known potential confounders, and the duration-re-
sponse relationship with years since smoking cessation in six
categories (1–1.9, 2–4.9, 5–9.9, 10–14.9, 15–19.9, 20) was
examined by trend test. We treated a variable (e.g., education
level) as a potential confounder if inclusion of such variable
made a 5% change (a more conservative criterion) in the
smoking OR, even if it was not statistically significant. All
potential confounding factors were included in the final
model to estimate the adjusted OR of smoking for the risk of
all lung cancers. We used the same strategies to identify
specific confounding factors for major histological types of
lung cancer: SQCC, ADC, SCC, and large cell carcinoma
(LCC). In addition, we used generalized additive models
incorporating cubic regression smoothing spline to model
nonlinear effects of years since smoking cessation on all lung
cancers and the major histological types after controlling for
most known potential confounding factors and other smoking
indices (i.e., number of cigarettes per day and years of
smoking). Analysis was conducted in R2.10.0 after loading
mgcv package (a library package that is installed in the
R2.10.0 to fit the generalized additive model).11 The mini-
mum Akaike’s information criterion (a measure of the good-
ness of fit of a statistical model) value was used as a guide for
selection of best model fit with different degrees of freedom.
We further performed two-stage fractional polynomial mod-
els to estimate the effect of years since smoking cessation
according to the approaches proposed by Royston et al.12 and
compared the model fit with the smoothing spline, and the
Akaike’s information criterion was very similar (Supplement
1, http://links.lww.com/JTO/A93). We chose the generalized
additive model with smoothing spline because it is a non-
parametric approach with a more flexible form to reflect the
data itself. All the models were repeated by replacing the
“number of cigarettes per day” and “years of smoking” by
“smoking pack-years.” Models with the former items showed
significantly better fits (p  0.05) and are reported here.
RESULTS
Sociodemographic Characteristics
The distributions of main sociodemographic information
for cases and referents are summarized in Table 1. Cases were
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more likely ever smokers (with the majority being current
smokers), alcohol drinkers, and born outside Hong Kong. They
had lower education attainment, more exposures to environmen-
tal tobacco smoke, and shorter duration of smoking cessation
among former smokers. Among the histological subgroups, a
higher proportion of ADC cases were never smokers. On the
other hand, all cases of SCC were ever-smokers, hindering the
proper quantification of the association with smoking. There was
no missing data for smoking status, and the missing data for
years since smoking cessation were very low in the cases
(0.75%) and referents (1.12%).
Cigarette Smoking and Lung Cancer Risk by
Histological Types
Table 2 presents the ORs for four major histological types
of lung cancer by smoking status. We observed much higher
crude ORs (only adjusted for age) of lung cancer for current
smokers than former smokers in all histological types, and the
strongest association was with SQCC (except for SCC with no
never smokers), followed by LCC, and then ADC. Multiple
logistic regression analyses showed that all the adjusted ORs
(except for the former smoking OR with LCC) were lower than
the crude ORs by 6 to 36%, indicating that confounding effects
of other risk factors were not negligible.
Effect of Smoking Cessation
Except for ADC, we observed an increased OR of lung
cancer for men who had quit smoking for less than 2 years
when compared with never quitters (Table 3). However, a
significantly negative gradient (p  0.001 for trend test) of
lung cancer risk was observed with increasing years since
smoking cessation (ordinal categorical scale) after 2 years.
TABLE 1. Sociodemographic Information and Smoking History of Lung Cancer Cases and Community Referents in Hong
Kong Males During 2004–2006
Characteristics
Major Types of Lung Cancer
Referents paSquamous Cell Adenocarcinoma Small Cell Large Cell All Cases
Total 272 (22.5) 440 (36.4) 118 (9.8) 25 (2.1) 1208 (100) 1069
Age (yr)b 68.0  8.7 65.0  9.7 67.2  8.1 63.2  10.6 65.8  9.5 66.2  9.9 0.326
Place of birthb
Hong Kong 35 (12.9) 114 (25.9) 20 (16.9) 8 (32.0) 266 (22.0) 397 (37.1) 0.001
Outside Hong Kong 237 (87.1) 325 (73.9) 98 (83.1) 17 (68.0) 941 (77.9) 672 (62.9)
Education levelb
Primary (6–11 yr) 80 (29.4) 97 (22.0) 39 (33.1) 6 (24.0) 298 (24.7) 142 (13.3) 0.001
High School (12–18 yr) 125 (46.0) 171 (38.9) 53 (44.9) 7 (28.0) 525 (43.5) 383 (35.8)
College (19 yr) 65 (23.9) 165 (37.5) 24 (20.3) 11 (44.0) 366 (30.3) 528 (49.4)
Alcohol drinking
No 91 (33.5) 150 (34.1) 49 (41.5) 10 (40.0) 445 (36.8) 541 (50.6) 0.001
Yes 181 (66.5) 287 (65.2) 68 (57.6) 15 (60.0) 756 (62.6) 518 (48.5)
Environmental tobacco smoke
Never 49 (18.0) 79 (18.0) 19 (16.1) 8 (32.0) 230 (19.0) 281 (26.3) 0.001
Ever 223 (82.0) 361 (82.0) 99 (83.9) 17 (68.0) 977 (80.9) 788 (73.7)
Status of smokingb
Never 5 (1.8) 89 (20.2) 0 2 (8.0) 132 (10.9) 536 (50.1) 0.001
Ever 267 (98.2) 351 (79.8) 118 (100.0) 23 (92.0) 1076 (89.1) 533 (49.9)
Formerc 85 (31.2) 124 (28.2) 26 (22.0) 5 (20.0) 340 (28.1) 357 (33.4)
Currentd 182 (66.9) 227 (51.6) 92 (78.0) 18 (72.0) 736 (60.9) 176 (16.5)
Years since cessationb 4.63  9.47 6.07  11.46 3.06  7.18 1.75  4.33 4.63  9.47 12.98  14.32
Never quitterse 170 (62.5) 219 (49.8) 83 (70.3) 17 (68.0) 691 (57.2) 169 (15.8) 0.001
1–1.9 12 (4.4) 8 (1.8) 9 (7.6) 1 (4.0) 45 (3.7) 7 (0.7)
2–2.9 9 (3.3) 13 (3.0) 2 (1.7) 2 (8.0) 33 (2.7) 19 (1.8)
3–3.9 8 (2.9) 8 (1.8) 1 (0.8) 0 25 (2.1) 13 (1.2)
4–4.9 4 (1.5) 9 (2.0) 1 (0.8) 1 (4.0) 23 (1.9) 13 (1.2)
5–9.9 17 (6.3) 16 (3.6) 7 (5.9) 0 65 (5.4) 55 (5.1)
10–14.9 14 (5.1) 14 (3.2) 5 (4.2) 1 (4.0) 54 (4.5) 53 (5.0)
15–19.9 10 (3.7) 16 (3.6) 4 (3.4) 1 (4.0) 44 (3.6) 47 (4.4)
20 22 (8.1) 44 (10.0) 4 (3.4) 0 87 (7.2) 145 (13.6)
Never smoker 5 (1.8) 89 (20.2) 0 2 (8.0) 132 (10.9) 536 (50.1)
Values are given as N (%) or mean  SD.
a Compare all lung cancer cases with community referents.
b Significant heterogeneities among histological subtypes (p  0.05).
c “Former smokers” referred to those who had quit smoking for 2 yr or more.
d “Current smokers” referred to those who had never quit smoking or quit smoking for less than 2 yr.
e “Never quitters” referred to those who had never quit smoking or quit smoking for less than 1 yr.
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The risk of SCC and SQCC decreased by around 83% and
78% within 5 years from smoking cessation and was the most
rapid among histological types. The OR of ADC decreased
less abruptly in the first 5 years (by 52%) but caught up
quickly in the next 5 years to 80%. A further decreased OR
(0.04) for SCC was observed after 20 years, but it was not
substantial for SQCC and ADC. Overall, the OR of SCC
decreased by 96% (95% CI: 83–99%) after a smoker contin-
ued to abstain from cigarette smoking for 20 years or more,
and the corresponding figures for SQCC and ADC were 85%
(95% CI: 67–93%) and 80% (95% CI: 65–89%), respec-
tively. In general, the risk could not revert back to that of
never smokers. A notable decreasing risk of LCC with in-
creasing years since smoking cessation was also observed
after 5 years of cessation, despite the less stable results due to
small number of cases. The changing risk of lung cancer with
increasing years of smoking cessation was better depicted
using smoothing spline analyses, which allowed the quanti-
fication of the impact over a full range of years since cessa-
tion on a continuous scale (Figure 1). We observed an early
rapid decrease in OR and an almost linear trend of the
decreased OR in the first 5 years after smoking cessation
across major histological types, whereas the estimates after-
ward were less stable.
Our study did not suggest an interaction between in-
tensity and years of smoking on the risk of all lung cancers
(ORinteraction  0.99, 95% CI: 0.93–1.06) and the major
histological types, and there was also no evidence for an
interaction between age of initiation and age of cessation for
smoking. Sensitivity analyses showed that the main results
did not change much after inclusion of other types of tobacco
consumption in the analyses (results omitted).
Reliability of Measurement
The test-retest reliability for smoking status, age at smok-
ing initiation and quitting, the amount, and years since smoking
cessation was excellent for both the cases (kappa or intraclass
coefficient ranged from 0.77 to 0.95) and the referents (kappa or
intraclass coefficient ranged from 0.83 to 0.95).
DISCUSSION
This study demonstrates a rapidly decreasing OR of
lung cancers across all major histological types in the first 2
to 5 years after smoking cessation. Each type of lung cancer
was strongly associated with current smoking but the OR
decreased substantially after smoking cessation. Overall, the
OR reduced by more than half (54%) in the first 2 to 5 years
of quitting, being 52%, 78%, and 83% for ADC, SQCC, and
SCC, respectively, and continued to decrease, at a slower
rate, in the subsequent years. The overall OR after smoking
cessation decreased up to 96% for SCC, 85% for SQCC, and
80% for ADC; however, it did not reduce down to that of
never smokers in general.
There is little doubt on a beneficial effect of reducing
lung cancer risk after quitting smoking,3,13 but the magnitude
of risk reduction may differ among different histological
types and vary among different populations. A meta-analysis
published in 2001 combined results of 14 studies from West-
ern populations (including both genders) and found that the
greatest reduction in OR in the first 5 years of cessation was
seen in SCC (19%, 95% CI: 10–27%), which was followed
by SQCC (16%, 95% CI: 10–22%), LCC (14%, 95% CI:
9–19%), and ADC (12%, 95% CI: 10–17%).3
TABLE 2. Odds Ratios (OR, 95% CI) for all Lung Cancers and the Major Histological Subtypes According to Smoking Status












Never 1.00 1.00 1.00 1.00 1.00
Ever 9.13 (7.29–11.43) 54.72 (22.34–134.03) 4.49 (3.42–5.89) — 14.78 (3.41–64.16)
Formerc 4.08 (3.17–5.25) 22.42 (8.96–56.05) 2.30 (1.68–3.16) — 4.43 (0.83–23.59)
Currentd 17.17 (13.34–22.10) 110.67 (44.76–273.65) 7.90 (5.85–10.66) — 27.70 (6.36–120.66)
Smoking status (adjusted
for most known potential
confounding factors)
Never 1.00e 1.00f 1.00g 1.00 1.00h
Ever 6.65 (5.25–8.42) 37.50 (15.21–92.51) 3.85 (2.91–5.09) — 13.85 (3.08–62.15)
Formerc 3.11 (2.38–4.07) 15.31 (6.06–38.68) 2.08 (1.50–2.88) — 4.53 (0.82–24.96)
Currentd 12.16 (9.34–15.84) 74.21 (29.78–184.96) 6.46 (4.75–8.79) — 23.42 (5.21–105.25)
Values are given as OR (95% CI).
a All cases with small cell were ever smokers.
b The model was only adjusted for the age at interview.
c “Former smokers” referred to those who had quit smoking for 2 yr or more.
d “Current smokers” referred to those who had never quit smoking or quit smoking for less than 2 yr.
e The model (all lung cancers) was adjusted for age, place of birth, education level, intake of meat, history of lung diseases, and exposure to occupational carcinogens.
f The model (squamous cell carcinoma) was adjusted for age, place of birth, education level, intake of meat, and history of lung diseases.
g The model (adenocarcinoma) was adjusted for age, education level, alcohol drinking, and history of lung diseases.
h The model (large cell carcinoma) was adjusted for age, education level, exposure to environmental tobacco smoke, history of lung diseases, any cancer in first-degree relatives,
consumption of fried food, and exposure to occupational carcinogens.
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We reviewed the 14 original studies cited in the meta-
analysis and found that only 8 studies in fact provided the risk
estimates by years of smoking cessation for lung cancer,14–21
and 7 of them presented results by histological types.14–19,21 All
seven were case-referent studies but only three15,17,19 of them
identified the referents from the general population. The study in
Germany (869 male cases, 165 female cases) showed a very
high OR of lung cancer (all lung cancers: 6.86; SQCC: 6.84;
SCC: 4.03; ADC: 10.24) in the first year of smoking cessation
compared with current smokers.19 The OR (1.18–1.81) was
still significantly increased 2 to 5 years after smoking cessa-
tion, it became borderline in the next 5 years, and then started
to decrease from the 10th year, with an overall decrease in
OR of 75% after 20 or more years of cessation.19 Age at
interview and smoking pack-years were adjusted, but age at
smoking initiation and other important confounding factors
(e.g., family cancer history and occupational exposures) were
not considered.19 The study in Canada (403 male cases, 442
female cases) assumed a linear relationship between OR and
years since smoking cessation but only presented results at 10
years: overall OR decreased by 35% in males and 48% in
females, with effects being slightly strong for SCC. Smoking
pack-year was the only variable being adjusted in the analy-
sis.17 The population-based study in Sweden included only
210 female cases with 30 ex-smokers, the overall OR de-
creased by 40% for the period 3 to 10 years after cessation,
and 70% after 10 years, while the risk estimates by histology
were very unstable because of small numbers.15
In an article published after the 2001 meta-analysis,
Rachet et al.22 used smoking data from a large population-
based case-referent study (640 lung cancer cases) conducted
in Montreal in the 1980s to show a likely linear trend in a
decreased OR of all lung cancers with an annual percentage
change of 7.3% (95% CI: 10.0 to 4.6%) after quitting
TABLE 3. Odds Ratios (OR, 95% CI) for all Lung Cancers and the Major Histological Subtypes According to Years Since












Years since cessation (adjusted
for age only)b
Never quittersc 1.00 1.00 1.00 1.00 1.00
1–1.99 1.58 (0.70–3.57) 1.65 (0.63–4.31) 0.86 (0.30–2.42) 2.67 (0.96–7.46) 1.38 (0.16–11.98)
2–2.99 0.44 (0.24–0.79) 0.42 (0.18–0.96) 0.56 (0.27–1.18) 0.19 (0.04–0.85) 1.20 (0.25–5.76)
3–3.99 0.48 (0.24–0.96) 0.56 (0.23–1.41) 0.48 (0.19–1.19) 0.15 (0.02–1.14) —
4–4.99 0.44 (0.22–0.90) 0.29 (0.09–0.91) 0.57 (0.24–1.37) 0.15 (0.02–1.14) 0.84 (0.10–6.88)
5–9.99 0.30 (0.20–0.45) 0.27 (0.15–0.48) 0.24 (0.13–0.44) 0.23 (0.10–0.53) —
10–14.99 0.26 (0.17–0.39) 0.23 (0.12–0.44) 0.22 (0.12–0.41) 0.17 (0.07–0.45) 0.21 (0.03–1.66)
15–19.99 0.24 (0.15–0.37) 0.18 (0.09–0.38) 0.29 (0.16–0.52) 0.15 (0.05–0.44) 0.25 (0.03–1.95)
20 0.15 (0.11–0.21) 0.13 (0.08–0.22) 0.26 (0.17–0.38) 0.05 (0.02–0.14) —
Never smoker 0.06 (0.05–0.08) 0.01 (0.00–0.02) 0.13 (0.09–0.17) — 0.04 (0.01–0.16)
Years since cessation (adjusted
for most known potential
confounding factors)
Never quittersc 1.00d 1.00e 1.00f 1.00g 1.00h
1–1.99 1.74 (0.74–4.05) 1.71 (0.60–4.88) 0.84 (0.28–2.54) 2.87 (0.89–9.23) 1.39 (0.13–15.33)
2–2.99 0.43 (0.23–0.80) 0.34 (0.14–0.82) 0.57 (0.26–1.24) 0.19 (0.04–0.87) 1.56 (0.25–9.90)
3–3.99 0.51 (0.24–1.08) 0.62 (0.22–1.75) 0.43 (0.17–1.12) 0.19 (0.02–1.63) —
4–4.99 0.46 (0.21–0.97) 0.22 (0.06–0.78) 0.48 (0.19–1.24) 0.17 (0.02–1.39) 1.40 (0.15–12.70)
5–9.99 0.28 (0.18–0.43) 0.22 (0.11–0.45) 0.20 (0.10–0.38) 0.19 (0.08–0.50) —
10–14.99 0.29 (0.18–0.48) 0.20 (0.09–0.44) 0.20 (0.10–0.40) 0.17 (0.06–0.52) 0.16 (0.02–1.45)
15–19.99 0.26 (0.16–0.44) 0.16 (0.07–0.38) 0.24 (0.12–0.47) 0.12 (0.04–0.42) 0.15 (0.02–1.45)
20 0.17 (0.11–0.28) 0.15 (0.07–0.33) 0.20 (0.11–0.35) 0.04 (0.01–0.17) —
Never smoker 0.13 (0.07–0.26) 0.02 (0.01–0.09) 0.14 (0.06–0.31) — 0.02 (0.00–0.28)
Values are given as OR (95% CI).
a All cases with small cell were ever smokers.
b The model was only adjusted for the age at interview.
c “Never quitters” referred to those who had never quit smoking or quit smoking for less than 1 yr.
d The model (all lung cancers) was adjusted for age, place of birth, education level, intake of meat, history of lung diseases, exposure to occupational carcinogens, and intensity
(number of cigarettes smoked per day).
e The model (squamous cell carcinoma) was adjusted for age, place of birth, education level, intake of meat, history of lung diseases, intensity (number of cigarettes smoked per
day), and years of smoking.
f The model (adenocarcinoma) was adjusted for age, education level, alcohol drinking, history of lung diseases, intensity (number of cigarettes smoked per day), and years of
smoking.
g The model (small cell carcinoma) was adjusted for age, place of birth, education level, intake of meat, history of lung diseases, exposure to occupational carcinogens, and
intensity (number of cigarettes smoked per day).
h The model (large cell carcinoma) was adjusted for age, education level, exposure to environmental tobacco smoke, history of lung diseases, any cancer in first-degree relatives,
consumption of fried food, exposure to occupational carcinogens, intensity (number of cigarettes smoked per day), and years of smoking.
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smoking, regardless of the amount or the duration of smok-
ing. Smoothing spline approach was incorporated in the
modeling of the effects of daily cigarette consumption, but no
further analysis was carried out according to different histo-
logical types of lung cancer.
Among three Asian studies evaluating the associations
between smoking cessation and lung cancer risk by histological
types among males,23–25 only two of them (conducted in Japan
and Taiwan) investigated years since smoking cessation and the
risks of major histological types of lung cancer (SQCC and SCC
combined; ADC) and showed a negative trend, but no statistical
significance was achieved due to few cases of former smokers
(Japan: 67; Taiwan: 39).24,25 In addition, the Japan cohort study
showed that the risks of lung cancer reached almost the same
level as that of never smokers after 20 years of smoking
cessation24; however, adjustment was only made for age. A
recently published cohort study among 45,900 Singapore Chi-
nese (with 463 lung cancers) showed a 28% (95% CI: 2–47%)
risk reduction after smoking cessation for an average of 5.8
years and a larger reduction (58%, 95% CI: 44–68%) was
observed for those quitting smoking longer; however, the rela-
tively short period of follow-up (5.8 years) for ascertainment of
adequate incidence cases precluded a more detailed analysis by
histological subtypes.26
Like the German study,19 our results showed a phenom-
enon of “quitting ill effect” (a higher risk) in the first years of
smoking cessation, which might have resulted from smokers
quitting smoking due to early symptoms related to lung
cancer before diagnosis. Nevertheless, our results indicated a
more rapidly decreased OR for all types of lung cancer during
the period 2 to 5 years after smoking cessation, with the
sharpest decrease for SCC. The discrepancy might be due to
our male smokers having longer smoking history (37.0 years)
and smoking heavier than other study populations (44.1
pack-years); however, no relevant information was provided
in the German study for a meaningful comparison. Compared
with previous population-based case-referent studies with
subgroup analyses according to histological subtype, our
study had the advantages of being the largest (1200 cases)
and with adequate adjustments for most known potential
confounding factors; hence, we believe that our results were
more reliable and valid than the previous studies. Barnoya
and Clantz demonstrated an accelerated reduction in lung
cancer incidence 2 years after the California Tobacco Control
Program was launched, providing supportive evidence on a
2-year window from the start of smoking cessation (quitting
ill effect) at a population level.27
Except for the two Canadian studies mentioned
above,17,22 previous studies using traditional “step function”
analysis, by grouping continuous years since quitting smoking
into distinct categories, provided insufficient flexibility in eval-
uating the impact of smoking cessation. The cutoff points used
to categorize the continuous variable were usually artificial and
might not have biological basis, thus useful information might
be lost within broad categories. On the other hand, simple
parametric regression analysis might result in inaccurate estima-
tion of the duration-response relationship when the true effect
was nonlinear. By performing flexible smoothing spline model-
ing and incorporating other smoking parameters (i.e., age at start
of smoking, the amount, and years of smoking) and most known
potential confounding factors in the analyses, results from our
study regarding the impact of smoking cessation should be more
accurate and informative in reflecting the true duration-response
relationship between smoking cessation and lung cancer. Our
results using both approaches consistently showed that the de-
creased OR of lung cancer was dependent on the time since
smoking cessation.
The rapidly decreased OR (56% for all lung cancers)
observed in the first 5 years after smoking cessation has
important clinical and public health implications (especially
for the cell types of SCC and SQCC) and provides a very
encouraging message to chronic smokers who are worried
about their high risk of lung cancer. This information would
be very useful for clinicians in coercing their chronic smok-
ing patients to quit smoking. Additional benefits are also
achievable by maintaining abstinence for longer periods. On
the other hand, the fact that the risk could not revert to that
among never smokers would act as a deterrent for young
people attempting to take up smoking.
Results of this large population-based case-referent
lung cancer study are valid and reliable and have been
discussed in detail elsewhere.28 The cases (96%) and refer-
ents (48%) had different participant rates, raising the possi-
bility of selection bias; nevertheless, major selection bias was
unlikely because the distributions of lung cancer histology in
our lung cancer cases and the smoking status of our commu-
nity referents were fairly similar to the general male popula-
FIGURE 1. Duration-response relationships of years since
smoking cessation for major histological types of lung can-
cer: (A) all lung cancers, (B) adenocarcinoma; (C) squamous
cell carcinoma; (D) small cell carcinoma. The curves were
estimated in generalized additive models using cubic regres-
sion spline with degree of freedom of 6, 6, 4, and 5 for all
lung cancers, adenocarcinoma, squamous cell carcinoma,
and small cell carcinoma, respectively.
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tion in Hong Kong.2,29 Interviewer bias and potential differ-
ential misclassification on smoking status were also less
likely because data from a special group of 64 subjects (who
had to undergo surgical operations for suspected lung cancer
and were handled as lung cancer cases during the interviews
but eventually were diagnosed as not suffering from lung
cancer) showed that the proportion of ever smokers and
smoking amount were different from the 228 surgically
confirmed lung cancer cases—part of the 1208 cases—but
similar to the community referents. However, we did not
obtain complete information on the use of filtered cigarettes,
characteristics of inhalation, and the brands, which might
limit further interpretations on the association with lung
cancer risks. Our estimates of the risk of LCC were imprecise
because of the small number of cases.
In conclusion, our study found that all histological
types of lung cancer were strongly associated with current
cigarette smoking, but the OR decreased substantially with
increasing years of abstinence from smoking, with the great-
est decline for SCC. We found a sharp decrease in OR of
more than 50% in the first 5 years of quitting for all major
histological types of lung cancer (except for LCC), and the
benefits obtainable within such a short period of abstinence
should convey an encouraging message to chronic smokers,
as well as clinicians and public health workers.
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